• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks

    M Pharmaceutical Announces Change to Board of Directors

    Matthew Spizziri
    Dec. 15, 2015 07:54AM PST
    Pharmaceutical Investing
    Company News

    M Pharmaceutical Inc. (CSE:MQ) announced that Dr. Martin Mintchev, PhD, has resigned from the board of directors of M Pharmaceutical Inc. and from his position as chief scientific officer with immediate effect.

    M Pharmaceutical Inc. (CSE:MQ) announced that Dr. Martin Mintchev, PhD, has resigned from the board of directors of M Pharmaceutical Inc. and from his position as chief scientific officer with immediate effect.
    M Pharma recently announced it had entered into a letter of intent to acquire reformulated orlistat from Chelatexx LLC (C-103) and a significant reorganization of its priorities to concentrate on the development of oral products for obesity treatment and weight loss. The management of M Pharma and Chelatexx LLC are currently reviewing the proposed acquisition structure for tax efficiency.
    M Pharmaceutical CEO, Matthew Lehman, stated:

    On behalf of the M Pharma board of directors, we thank Dr. Mintchev for his service to help start the company. His creative insights are the driving factor behind much of M Pharma’s innovative technology. We wish him well with his teaching and research endeavours.

    Connect with M Pharmaceutical Inc. (CSE:MQ) to receive an Investor Kit

    martin mintchevboard of directorsm pharmaceutical inc.weight loss
    The Conversation (0)

    Go Deeper

    AI Powered
    Medical pills branded with Canadian flag.

    Canadian Pharma Stocks: 5 Biggest Companies

    Canada maple leaves on left and pharmaceutical pills in red and blue on right.

    5 Best-performing Canadian Pharma Stocks (Updated January 2025)

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    Ă—